Arvinas Inc (ARVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARVN | BMY | AMGN | GILD | REGN |
| Company | Arvinas Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 34.09 | 48.21 | 264.63 | 66.25 | 913.97 |
| High | 34.63 | 48.67 | 267.64 | 66.72 | 920.73 |
| Low | 33.73 | 48.12 | 260.68 | 66.16 | 891.61 |
| Last | 33.94 | 48.49 | 266.58 | 66.27 | 892.98 |
| Change | -0.35 | +0.19 | +3.83 | +0.11 | -1.01 |
| % Change | -1.02% | +0.39% | +1.46% | +0.17% | -0.11% |
| Volume | 133,879 | 2,756,813 | 892,088 | 2,719,390 | 167,142 |
| 20-Day Average Volume | 518,294 | 10,918,940 | 2,118,220 | 6,051,213 | 420,534 |
| Previous Close | 34.29 | 48.30 | 262.75 | 66.16 | 893.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 37.79 | 50.84 | 272.45 | 69.88 | 934.96 |
| 20-Day Raw Stochastic | 15.82% | 13.92% | 21.66% | 6.09% | 2.20% |
| 20-Day Relative Strength | 33.42% | 39.11% | 41.54% | 29.22% | 32.98% |
| Weighted Alpha | -18.55 | -29.62 | +6.45 | -24.91 | +11.65 |
| Today's Opinion | 8% Buy | 72% Sell | 56% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 8% Buy | 72% Sell | 56% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 56% Buy | 24% Sell | 8% Sell | 72% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.58% since 04/12/24 | +0.60% since 04/12/24 | -0.21% since 04/12/24 | -2.48% since 04/12/24 | -1.37% since 04/12/24 |
| Low | 32.61 on 04/18/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 37.00 on 04/15/24 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 921.12 on 04/15/24 |
| 1-Month | |||||
| %Chg | -19.49% since 03/19/24 | -6.24% since 03/19/24 | -1.84% since 03/19/24 | -9.57% since 03/19/24 | -7.40% since 03/19/24 |
| Low | 32.61 on 04/18/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 44.85 on 03/21/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 979.26 on 03/21/24 |
| 3-Month | |||||
| %Chg | -5.92% since 01/19/24 | -3.07% since 01/19/24 | -13.35% since 01/19/24 | -23.95% since 01/19/24 | -4.40% since 01/19/24 |
| Low | 32.61 on 04/18/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 53.08 on 02/16/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +124.25% since 10/19/23 | -14.00% since 10/19/23 | -4.95% since 10/19/23 | -15.37% since 10/19/23 | +10.35% since 10/19/23 |
| Low | 13.57 on 10/27/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 769.19 on 10/27/23 |
| High | 53.08 on 02/16/24 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,342,281 | 97,892,464 | 140,812,720 | 82,374,304 | 98,126,128 |
| Shares Outstanding, K | 68,308 | 2,026,759 | 535,919 | 1,245,077 | 109,762 |
| Annual Sales | 78,500,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -367,300,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 34,600,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -64,000,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 1.94 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.53 on 02/27/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/03/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.38 | 14.16 | 9.96 | 23.98 |